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To assess the Interrelation of clinical and procedural factors
responsible for restenosis, 119 patients undergoing coro-
nary arterlography were studied a mean or5.8 ± 3 months
alter successful multiple pmvtaneous transiaminat coro-
nary angioplasty
. In all clinical, angiographic and prone.
durst variables, the 119 patients undergoing repeat clubs,
terfration were similar to the 87 patients that did not
.
Overall, restenosis occurred In 74 (34%) of 215 lesions .
Sixty-three patients had no restemsls, 44 had at least one
restenosis and 12 had restenosis at all angioplasty sites . The
statistical distribution of restenosis did not follow a bino-
mial model, suggesting that restenosis is more than a
lesion-specific phenomenon
.
Of all the clinical and procedural variables assessed by
multivariate logistic regression analysis, only percent ste-
nesis before angioplasty (p < 0 .01), diabetes mellitus (p <
Multivessel coronary angioplasty is now used to treat more
patients (1,2),
but restenosis remains the major limitation of
the procedure . Medical trials to prevent restenosis have
been disappointing
(3), probably partly because of the mul .
tiplicity of
recurrent,--related
factors . Balloonlartery lumen
ratio (4), maximal inflation pressure
(5-8) and stenosis after
angioplasty (4,7,9) have been demonstrated to influence
restenosis
. Likewise, reports have suggested that diabetes
mellitus
(6,10), unstable angina (9) and hyperlipidemia (6)
also play a role
. However, the respective importance of
these procedural and clinical factors remains undetermined .
An approach to assess the relative influence of systemic
versus local factors would be to compare patients with
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0 .01) and percent genesis after a ngioplasty (p < 0 .05) were
predictive of restenosis in the entire group . Patients with do
restenosis and patients with restenosis at all sites were not
different with respect to procedural variables
; however,
patients with restenosis at all sites more often (p < 0 .05)
had diabetes and recent mutt angina . In contrast, patients
with no restenosis differed from patients with Isolated
restenosis with respect to procedural variables : severity of
stenosis before and after angioplasty, bafloodartery lumen
ratio and maximal Inflation pressure. TMts, procedural
factors may be ∎axe related to Isolated restegauseds, but
patient-related factors such as diabetes and recent onset
angina may play a more important role be patients with
multiple restenoses.
(J
Am
Call Card0ol 1988,12.310-4)
multiple restenases with patients with isolated restenosis
after multiple coronary angioplasty . Thus, we tested the
hypothesis that systemic or patient-related factors might be
more common with restenosis at all sites, and that lesion-
related or procedure-related factors might be more frequent
in association with an isolated restenosis . The pattern of
restenosis after multiple coronary angioplasty was also ex-
amined to determine whether it followed the expected bino-
mial distribulon .
Methods
Study patients. Between December 1981 and January
1986, 1,448 patients underwent a first elective coronary
angioplasty at the Montreal Heart I
.istitote. At least two
lesions were dilated in 206 of
these patients, who form our
study group; primary success rate and complication rate in
these patients have previously been published (11). Not
included were patients who had a repeat procedure for
resienosis or who underwent angioplasty of saphenous vein
0735.10971tw03.30
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Table 1 . Characteristics of 206 Patients With and Without Repeat Calheteriaalion After
Coronary Angioplasty
grafts or coronary angioplasty during acute myocardial in-
farction
.
Angioplasty procedure. All dilated segments were studied
prospectively by measuring arterial diameter pro ;imal and
distal to the stenosis to determine optimal balloon size . The
degree of stenosis was measured with a caliper in the view
showing the most severe stenosis and was expressed as a
percent of luminal narrowing as compared with the closest
normal segment . All measurements were made by an inde-
pendent experienced radiologist
. All angioplasty procedures
were performed by way of a percutaneous femoral approach
as previously described (4) . Since April 1983, on the basis of
our previous experience, we have tended to use higher
inflation pressures (8 to 12 atm).
Angioplasty was attempted on two sites in 148 (72%) of
the 206 patients, on three sites in 45 patients (22%), on four
sites in It patients (5%) and on five sites in only 2 patients
(1%) . The procedure was angiographically and clini-ally
successful (defined as successful dilation of all lesions or of
the most important lesion with clinical improvement) in 185
patients (90%) . Of these 185 patients, angiographic follow-up
was available in 119 (64%). Clinical, angiographic and pro-
cedural characteristics of these patients who underwent
repeat catheterization were similar to those of the 87 patients
who did not (Table 1) .
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Differences between groups not statistically significant . C! VS = Canadian Cardiavescuhr Society: HDL = high
density lipoprotein : LDL = low density lipoprotein .
Medications. During the procedure, all patients received
5 .000 U heparin . Administration of aspirin (650 mg(day) and
dipyridamole (75 mg three times daily) was begun I day
before angioplasty and continued for 6 months thereafter
when the procedure was successful. Diltiazem (60 or 90 mg)
was administered the evening before and the morning of
angioplasty; in some patients, diltiazem was continued for 6
months (12).
Follow-up. Coronary arteriogmphy was recommended to
all patients at 6 months but was done earlier in those with
recurrent angina
. The average time to angiographic fol-
low-up was 5 .8 ± 3 months after angioplasty .
Data analysis. Severity of angina was graded according to
the Canadian Cardiovascular Society classification
(13) . Un-
stable angina was defined as angina of increasing severity,
including pain at rest, or new onset angina (sl month) .
Diabetes was diagnosed if the fasting blood sugar, measured
in all patients, was > 140 mg/dl or if insulin or oral hypogly-
cemic drugs were already prescribed . Intimal dissection was
defined according to National Heart, Lung, and Blood
Institute criteria (14). Primary angioplasty success was de-
fined as a stenosis reduction >20% with a residual stenosis
diameter <50% in the absence of major complications (clec-
trocardiog aphic or enzymatic evidence of myocardial in-
patients With
Repeal
Calhcmriralion
bursts Without
Report
Cotheterioation Total
No
. of patients
119 87
206
Age
(YO
Imoan t SDI
54
t 9 Wx9 54_9
Male 92 (775:
.1 70 (8 )
162 (779'0)
Duration of angina (mo) 21 _ 25 19022 20_23
Previous
my-dial
infarction 32127 .%) 24(2771 56(27%)
Previous bypass surgery 615%) 5 (6%) 110%)
s y uem;c
hy
penension 411347
.1 30135%) 70(34%)
Diabetes mellitus I3(11%%) 10 (12701 33111%)
Cigarette smoking 86 )72%) 63 (7471 (49
1
72%01
LDL cholesterol Imgldli 163 t 50 166 x 49 165 0 50
HDL cholesterol (00(d)) 39 x 12 39 _ 13 39= 12
Triglycerideslmr)dll 196 x 90 206x89 199 x 90
CCVS functional class
0 to 1 7 )6%) 2 I:%) 9(495)
2
40(34%) 33179%)
74136%)
3104 7222 )60) 50(59%) 12.30)
Recent onset angina (sl mot 231(9%x) 15(18%) 38(18%I
Primary sueeess (40 00 a les) 2)5 )78%) (76(81%) 391(8175)
Slenosis diameter (%)
Before angioplasty 74 I4 74x14 74x14
After angioplasty 33t l9 33 x 20 33 '- 20
Intimal dissection (% of sites) 123 145%) 93)46%) 216(45%)
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farction, bypass surgery during hospitalization or in-hospital
death).
Reslenosis it-as assessed twine three definitions: I) resid-
ual stenosis >50% of luminal diameter ; 2) loss of ?50% of
the gain in vessel diameter achieved at angioplasty ; and 3)
increase >30% in the immediate postangioplasty stenosis
.
Univariate analysis was performed with the chi-square
S•-
test for categorical data and the unpaired t test for continu-
ous variables. Multivariate analysis was performed by step-
wise logistic regression to identify variables predictive of
restenosis.
A chi-square goodness of fit lest bras employed
to deter-
mine ndietl,er the restenosis data were compatible with a
binomial distribution model (15). The binomial distribution
defines the likelihood of an all or none event (that is,
restenosis) occurring in a given number of trials (that is,
angioplasty sites). The per lesion restenosis rate used in the
model was 34% when restenosis was defined as residual
stenosis >50% of luminal diameter (preceding definition 1)
.
This rate was derived from a nearly consecutive series of
restudied patients who had undergone single vessel angio-
plasty at our institute during the same period as the study
population. Only the 87 patients with two angioplasty sites
successfully dilated were included in the binomial distribu-
tion model
; separate models were not constructed for pa-
tients with three or more sites dilated because the numbers
of patients in these groups were too small . A difference in the
observed pattern of restenosis from that predicted by the
binomial distribution implies that restenosis does not occur
randomly but is influenced by patient-related factors .
Results
Incidence of restenosis . Two hundred fifteen lesions had
been successfully dilated in the 119 patients with repeat
catheterization
. When defined by definition 2 (loss of >_50%
of the gain achieved), the restenosis rate was 38% (82 of
215)
. When defined as as increase in diameter stenosis >30%
(definition 3), restenosis occurred in 66 lesions (31%)
.
Restenosis defined as >50% diameter stenosis (definition I)
was present in 74 lesions (34%) .
Statistical distribution. We tested the hypothesis that
restenosis after double-lesion angioplasty followed the pre .
dicted binomial distribution (Fig. I). The observed pattern of
restenosis did not follow the expected distribution and the
difference is statistically significant (p < 0 .05).
Clinical, anglographic and procedural variables related to
restenosis. Stepwise logistic regression analysis was per-
formed on the 119 patients with repeat catheterization to
identify restenosis-related factors (Table 2) . In order of sig .
nificance the factors were preangioplasty stenosis (p = 0.005),
diabetes mellitus (p = 0
.003) and residual stenosis (p = 0 .046) .
Our study group contained 12 patients (10%) in whom
all
dilated lesions developed restenosis . Seven of these patients
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Figure 1. The observed pattern of restenosis among the 87 patients
with double-lesion angioplasty is compared with the pattern pre-
dicted by the binomial distribution (15). If restenosis occurred
randomly, it would follow the binomial distribution . The difference
between the two (p < 0 .05) implies that patient-related, and not just
lesion-related, variables influence restenosis
.
had restenosis at both of two dilated sites, two patients at all
of three dilated sites and three patients at all of four dilated
sites . In 63 (53%) of the 119 restudied patients, all dilated
lesions were patent at repeat catheterization
. In the remain-
ing 44 cases (37%), some lesions developed restenosis but
others did not .
Diabetes mellitus and recent onset angina (s1 month)
were more frequent in patients with restenosis at all sites
than in patients with no restenosis (Table 3). Among the 12
patients with multiple rstenoses, 3 (25%) had diabetes
versus 4 (6%) of 63 (p < 0
.05) in the no restenosis group, and
5 (42%) had recent onset angina versus 9 (14%) of 63 (p <
0.05) in the no restenosis group . These two groups, however,
did not differ with respect to any of the procedural variables
listed in Table 3 .
In contrast, the 44 patients with an isolated restenosis,
when compared with the group without restenosis, had more
severe lesions before angioplasty (79 t 7% versus 69 ± 8%,
p < 0
.01), mare severe slenoses after angioplasty (35 t 5%
Table 2 . Multivariate Stepwise Logistic Regression Analysis of
Risk Factors for Restenosis in 119 Patients
Constant = -0.63656
Variables Entered Chi-square p Value Coefficient
Increased
Rate of
Restelmsis
Preangioplasty 19.9 0 .005 0.3891 High glade
stenosis
stenosis
Diabetes mellitus 12.2 0
.003 0.5540 Presence vs .
absence
Postangioplasty 8.2 D.046 0.3194 Large residual
stenosis
stenosis
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NS = not significant ; other abbreviations as in Table I .
versus 27 ± 8%, p < 0 .01), a lower balloonlartery lumen
ratio (p < 0.05) and higher maximal inflation pressures (p <
0.05). On the other hand, these two groups did not differ
significantly with respect to any of the patient-related factors
(Table 3) .
Discussion
Systemic factors influencing postangioplasly restenosis .
This study shows that restenosis after multiple coronary
angioplasty does not follow the expected binomial distribu-
tion. Thus, the occurrence of restenosis at any site is nut
independent of the outcome of other lesions. This finding
implies that systemic factors influence restenosis . By multi-
variate analysis, restenosis correlated with two procedural
variables and one clinical variable, diabetes . In other stud-
ies, clinical factors such as diabetes (6,10), gender (5,9),
smoking (6), dyslipidemia (6) and recent onset angina (5,6,9)
have been associated with restenosis by univariale or mul-
tivariate analysis. The nonbinomial distribution of reste-
noses found in our study accents the potential importance of
these systemic variables.
Systemic factors might be expected to be more evident in
patients with restenoses at all sites and lesion-related or
procedure-reiated factors more evident with isolated resten-
osis . Such a pattern was found in our study
. Diabetes and
recent onset angina were more frequent in the patients with
restenosis at all sites. Patients with isolated restenosis and
patients without restenosis did not differ with respect to
L\MBERT ET AL .
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Table 3. Comparison of Restenosis Factors Between Patients With
No
Restenosis
. Isolated Restenosis and Multiple Restenosis
clinical variables; however, procedural variables-severity
of stenosis before and after angioplasty . balloon/artery lu-
men ratio and maximal inflation pressures-were signifi-
cantly different in these two groups . These procedural vari-
ables did not distinguish patients with restenosis at all sites
from those without restenosis . Myler et al . (6) also found
that diabetes and a shorter duration of angina were more
frequent in patients with restenosis at all sites . Hypercho-
lesterolemia and smoking were also more prevalent in this
group . Patients with no restenosis differed from patients with
isolated restenosis with respect to procedural variables, as
found in our study .
Pathophyslology of restenosis
. The mechanisms whereby
systemic factors contribute to restenosis are not known .
Pathologic findings in patients who die after coronary angio-
plasty show a uniform proliferation of smooth muscle cells in
the intima of the artery (16). Platelet-derived growth factors
hate been reported (17) to promote growth of cultured
smooth muscle cells. Experimental studies (48,49) suggest
than mural thrombus, platelet accumulation and release of
p!atelet growth factors may be the predcm!naat mechanisms
causing restenosis . During unstable or recent onset angina .
platelets release vasoactive substances, including growth
factors (20) . Likewise, proliferation of smooth muscle-type
cells in the mesangium of the kidney in diabetic patients (21)
bears some similarity to smooth muscle proliferation in
restenosis . Ledet et al . (22) established that a factor capable
of stimulating the proliferation of rabbit and human aortic
smooth muscle cells is present in increased concentrations in
Group A' Multiple
Restenoscs
112 palicms)
p Valuc
Group R : No
Reacnosis
163
p0100101 p Valve
Lesions With
Restemsis
150 patients)
Group C: W0106
Restenwes
144 patients)
Lesions W4Ihoul
Reslcnosis
1)4
pitch)
Age (yn (mean m SD) 54 0 9 NS 51 x 7 N5 54-5
Male 10 of 12 18351) NS 48 of 63176$) NS 14 of 44177.4)
Ummble angina 61 of 12 (5 ) NS 18 of 63 29v4I NS 10of44)23%)
Previous myocardial
infarction
4 of 12 (3391 N5 15 of 63 61',1 IS 13 of 44(3041
5
of
12 (429)Recent onset angina
<0.05 9 of 63 114 ..^1 NS 9of4)C7b1
Hypertension 16 of 12 ( 50%) NS 19 of 61129";
)
NS
16 of 44136%)
Diabetes mellitus 3 of 12125%4) <0.05 4 of 631644) NS
6 of 44 (14%)
Smoking 7 of 12(58%) NS 47 of 63 (757.1 NS 32 of 44 (73441
LDLcholesterol (mg/d1) 166
.
49 NS 155 x 5)1 NS 156 x 49
Triglyaerides(mg/61) 192
0
75 NS 193 n 85 NS 191 _ 82
Preangioplasly (90)
slenosis
70.2 0 3 NS 68 .9 o 8 <0.01 79.0x7 7,)04
Postangioplastyl4)
stenusR
28.2 0 6 NS 26,9 ± 8 <0,01
34.805 27 .9x5
RaOoodsnery lumen ratio 1.17
0
0 .12 NS 1 .15 x 0 .17 <305 1.0500.16 1 .11_0.13
Maximal inflation pressure
atm)
8 .15
0
1 .2 NS
8
.03 x 1 .5 <0.05 8.78 x 1.2 8.15 0 I4
10 of 22 (4590)Imimat dissection
)lesions)
NS 52 of 109 147%) NS
25of43071 15of34(53%)
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the serum of patients with nortnolipemic type I diabetes
; this
factor may be growth hormone (23) . Furthermore, platelet
abnormalities, including increased reactivity laggregation
and adhesion), spontaneous aggregation and diminished sur-
vival, were found in diabetics (24,25) . Platelets from diabetic
patients showed reduced prostacyclin production (26) and
enhanced thromboxane A2 synthesis (27), a condition pro-
moting platelet aggregation
.
Limitations of the study. Only 64% of our patients with
successful coronary angioplasly underwent repeat catheter-
ization . Furthermore, more patients with than without recur-
rence of symptoms were restudied, probably biasing the
restenosis rate. However, the main goal of this study was to
examine the variables related o carer sic rather than t
measure the rate of restenosis itself, and for this purpose the
data are accurate .
All patients received aspirin and dipyridamole beginning
I day before the procedure and continuing for 6 months
thereafter . Although experimental work (28) suggested that
antiplatelet agents influence restenosis, these drugs failed to
reduce the rate of restenosis in two recent multicenter,
double-blind, placebo-controlled trials (29,30) and were un-
likely to have influenced the pattern
of restenosis in our
patients .
Conclusions . This study strongly suggests that multiple
coronary restenoses after angioplasly are caused by patient-
related factors. Under such conditions, interventions aimed
at risk factor modification may be helpful . Isolated restenosis
appears to be more influenced by procedural variables and
thus may require a more mechanical solution, such as stems
(31). These conclusions are speculative because the patho-
physiologic mechanisms causing restenosis remain undefined,
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